Financials
- Market Capitalization 9.67 B
- Employee 141
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-42.6
Fiyat/satışlar oranı
120.66
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 917 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.80 USD | +1.42% | +1.72% | -2.06% | +101.29% | 10.15 B USD | ||
| 925 | KYMR Kymera Therapeutics, Inc. - Common Stock | 120.23 USD | -4.24% | -2.15% | +14.50% | +103.43% | 10.00 B USD | ||
| 981 | PCVX Vaxcyte, Inc. - Common Stock | 61.16 USD | +0.11% | -1.12% | +12.22% | +44.59% | 9.10 B USD | ||
| 983 | IMVT Immunovant, Inc. - Common Stock | 43.82 USD | -0.16% | -2.03% | +12.42% | +128.11% | 9.05 B USD |